Crossmark

Chemotherapy-driven increases in the CDKN1A/PTN/PTPRZ1 axis promote chemoresistance by activating the NF-κB pathway in breast cancer cells

Crossref DOI link: https://doi.org/10.1186/s12964-018-0304-4

Published Online: 2018-11-29

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Huang, Peng

Ouyang, Deng-jie

Chang, Shi

Li, Mo-yun

Li, Lun

Li, Qian-ying

Zeng, Rong

Zou, Qiong-yan

Su, Juan

Zhao, Piao

Pei, Lei

Yi, Wen-jun https://orcid.org/0000-0002-1563-4925
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81441084)

Natural Science Foundation of Hunan Province (2015jj4059)

Development and Reform Commission of Hunan Province (2014658)
License Information

Text and Data Mining valid from 2018-11-29
More Information

Article History

Received: 2 August 2018

Accepted: 15 November 2018

First Online: 29 November 2018

Ethics approval and consent to participate

: Not applicable.

: All authors have read and approved the final manuscript and consented to its publication.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.